Literature DB >> 7641405

Appearance of Graves'-like disease after radioiodine therapy for toxic as well as non-toxic multinodular goitre.

B Nygaard, J Faber, A Veje, L Hegedüs, J M Hansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7641405     DOI： 10.1111/j.1365-2265.1995.tb01904.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  6 in total

1.  Graves' disease after percutaneous ethanol injection for the treatment of autonomous thyroid adenoma.

Authors:  G Verde
Journal:  J Endocrinol Invest       Date:  1998-05       Impact factor: 4.256

2.  Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.

Authors:  C Regalbuto; S Salamone; C Scollo; R Vigneri; V Pezzino
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

Review 3.  131I-Induced Graves' disease in patients treated for toxic multinodular goitre: systematic review and descriptive analysis.

Authors:  C Roque; C A Vasconcelos
Journal:  J Endocrinol Invest       Date:  2018-01-20       Impact factor: 4.256

4.  [Incidence of immunogenic hyperthyroidism after radioiodine therapy of focal thyroid gland autonomy. Results of a multicenter study].

Authors:  M Weiss; R Görges; C Hirsch; J Bader; K Tatsch; K Hahn
Journal:  Med Klin (Munich)       Date:  1999-05-15

5.  Presence of Thyroid-Stimulating Hormone Receptor Antibodies in a Patient with Subacute Thyroiditis followed by Hypothyroidism and Later Graves' Disease with Ophthalmopathy: A Case Report.

Authors:  Bengt Hallengren; Tereza Planck; Peter Åsman; Mikael Lantz
Journal:  Eur Thyroid J       Date:  2015-07-18

6.  Graves Disease Induced by Radioiodine Therapy for Toxic Nodular Goiter: A Case Report.

Authors:  Yakup Yürekli; Arzu Cengiz; Engin Güney
Journal:  Mol Imaging Radionucl Ther       Date:  2015-10-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.